Acadia Healthcare Hits Day High with 11.67% Surge in Stock Price

Acadia Healthcare Co., Inc. has experienced a significant uptick in its stock performance, gaining 11.67% on September 24, 2025. The stock reached an intraday high of USD 24.63, marking a notable achievement for the small-cap company within the Pharmaceuticals & Biotechnology sector.
In terms of performance metrics, Acadia Healthcare's one-day performance stands at 11.82%, contrasting sharply with the S&P 500's decline of 0.55%. Over the past week, the stock has risen by 9.58%, while its monthly performance reflects a modest increase of 3.15%. However, the company has faced challenges over the longer term, with a one-year performance decline of 64.66%, significantly underperforming the S&P 500, which has gained 16.41% during the same period.

Despite the recent gains, Acadia Healthcare's financial indicators reveal a complex picture. The company has reported negative results for the last four consecutive quarters, with a net profit decline of 30.71%. Additionally, the debt-equity ratio stands at a high 73.24%, indicating potential financial strain. As the stock continues to navigate these dynamics, its recent high reflects a momentary rebound in a challenging landscape.